Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

HilleVax
75 State St., Suite 100
Boston, MA 02109
Phone: 617-213-5054
https://www.hillevax.com/

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccine candidates. Its initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.

Key Contact
Name
Rob Hershberg
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
09/08/21 $135,000,000 Crossover Financing Abingworth
BVF Partners
Catalys Pacific
Deerfield Management Company, L.P.
Franklin Templeton
Frazier Healthcare Partners
Greenspring Associates
Lightspeed Venture Partners
Perceptive Advisors
Qiming Venture Partners
RA Capital Management
Samsara BioCapital


Featured Reading